Its mechanism of action is largely based on the impairment of the cancer cell energy metabolism by inhibiting HK2 (Hexokinase 2) and GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) resulting in ATP reduction. The gene discussed is HK2; the disease is cancer.